Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (111-120 of 548) with videos related to

Pageof 55
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 16, 2017
High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosisChristine Rousset-Jablonski, Quitterie Reynaud, Raphaëlle Nove-Josserand, et al.
ESMO Open|December 14, 2020
First-line PARP inhibitors in ovarian cancer: summary of an <i>ESMO Open - Cancer Horizons</i> round-table discussionSusana Banerjee, Antonio Gonzalez-Martin, Philipp Harter, et al.
Nature Reviews. Disease Primers|December 10, 2021
Endometrial cancerVicky Makker, Helen MacKay, Isabelle Ray-Coquard, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for the treatment of soft tissue sarcomasPhilippe A Cassier, Armelle Dufresne, Jérôme Fayette, et al.
Journal of the National Cancer Institute|July 1, 2026
Response to Yu, Wang and GeFlorence Joly, Amélie Anota, Sylvie Chabaud, et al.
Future Oncology (London, England)|March 17, 2021
Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancerOlivia Le Saux, Hélène Vanacker, Fatma Guermazi, et al.
Pediatric Blood & Cancer|February 21, 2009
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancerPerrine Marec-Berard, Pascal Chastagner, Diana Kassab-Chahmi, et al.
Bulletin Du Cancer|May 23, 2008
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)]Isabelle Ray-Coquard, Diana Kassab-Chahmi, Nicole Casadevall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2018
Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)Magali Girodet, Anne-Déborah Bouhnik, Julien Mancini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 6, 2008
[Standards & options: recommendations for the use of erythropoiesis-stimulating agents (ESA) in anaemic cancer patients undergoing radiotherapy (2007 update)]Christian Marchal, Jean-Louis Misset, Nicole Casadevall, et al.
Pageof 55

Showing results (111-120 of 548) with videos related to

Sort By:
Pageof 55
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 16, 2017
High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosisChristine Rousset-Jablonski, Quitterie Reynaud, Raphaëlle Nove-Josserand, et al.
ESMO Open|December 14, 2020
First-line PARP inhibitors in ovarian cancer: summary of an <i>ESMO Open - Cancer Horizons</i> round-table discussionSusana Banerjee, Antonio Gonzalez-Martin, Philipp Harter, et al.
Nature Reviews. Disease Primers|December 10, 2021
Endometrial cancerVicky Makker, Helen MacKay, Isabelle Ray-Coquard, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for the treatment of soft tissue sarcomasPhilippe A Cassier, Armelle Dufresne, Jérôme Fayette, et al.
Journal of the National Cancer Institute|July 1, 2026
Response to Yu, Wang and GeFlorence Joly, Amélie Anota, Sylvie Chabaud, et al.
Future Oncology (London, England)|March 17, 2021
Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancerOlivia Le Saux, Hélène Vanacker, Fatma Guermazi, et al.
Pediatric Blood & Cancer|February 21, 2009
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancerPerrine Marec-Berard, Pascal Chastagner, Diana Kassab-Chahmi, et al.
Bulletin Du Cancer|May 23, 2008
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)]Isabelle Ray-Coquard, Diana Kassab-Chahmi, Nicole Casadevall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2018
Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)Magali Girodet, Anne-Déborah Bouhnik, Julien Mancini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 6, 2008
[Standards & options: recommendations for the use of erythropoiesis-stimulating agents (ESA) in anaemic cancer patients undergoing radiotherapy (2007 update)]Christian Marchal, Jean-Louis Misset, Nicole Casadevall, et al.
Pageof 55